Help Set the Priorities for Paediatric Sepsis Research

Each year, around 25.2 million children worldwide are diagnosed with sepsis, with more than 3.4 million tragically dying from the condition. Despite this devastating impact, there are still many unanswered questions about how best to diagnose, treat, and care for children with sepsis. 

That’s why the Paediatric Adaptive Sepsis Platform Trial (PASSPORT) team has partnered with the James Lind Alliance to run the Paediatric Sepsis Research Priority Survey.  

This international survey invites patients, parents, carers, and health care professionals to share their views on the most important unanswered questions about sepsis in children.  

The findings will directly shape the design of PASSPORT, a groundbreaking adaptive platform trial set to begin in 2027. By focusing on the priorities identified by the community, PASSPORT aims to deliver faster answers and improve outcomes for critically ill children. 

🎈 Take part and share your voice.